Insider screener

Period: 12 months Type of trade: Sold × Plan: Discretionary × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,196 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,196 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,196 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,196 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,196 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,196 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,196 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
VICENTE MONICA SVP, Chief Financial Officer
Sold at will
$76.11K 1,775 at 42.88
9.8%
Not planned
2 Mar 2026
WILDER C JOHN 10% owner · indirect
Sold at will
$75.78K 22,224 at 3.41
0.1%
Not planned
2 Mar 2026
ROSINUS MIKE Director · indirect
Sold at will
$72.50K 2,499 at 29.01
1.9%
Not planned
2 Mar 2026
Moreland Mary K EXECUTIVE VICE PRESIDENT
Sold at will
$70.85K 613 at 115.58
0.6%
Not planned
2 Mar 2026
MCCOY JOHN A. JR. VICE PRESIDENT AND CONTROLLER
Sold at will
$67.61K 585 at 115.58
2.3%
Not planned
2 Mar 2026
Powell Mary Chief Executive Officer
Sold at will
$66.07K 5,357 at 12.33
0.5%
Not planned
2 Mar 2026
Berkley Neil Lindsay CFO & Chief Business Officer
Sold at will
$62.95K 29,649 at 2.12
7.9%
Not planned
2 Mar 2026
Wu Naixi Chief Financial Officer
Sold at will 2×
$61.15K 17,162 at 3.56
18.2%
Not planned
2 Mar 2026
SILVA EFFIE D SVP, General Counsel & Secy
Sold at will
$58.53K 1,365 at 42.88
11.7%
Not planned
2 Mar 2026
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will
$57.53K 1,513 at 38.02
3.6%
Not planned
2 Mar 2026
HIRSCHHORN MARK Chief Financial Officer
Sold at will
$56.57K 10,796 at 5.24
5.0%
Not planned
2 Mar 2026
Hernandez Gerardo Chief Financial Officer
Sold at will
$52.17K 375 at 139.12
2.5%
Not planned
2 Mar 2026
Abajian Danny Chief Financial Officer
Sold at will
$51.70K 4,193 at 12.33
0.7%
Not planned
2 Mar 2026
Eagle Point Credit Management LLC 10% owner · indirect
Sold at will 2×
$51.54K 2,140 at 24.08
0.6%
Not planned
2 Mar 2026
Smethurst Dominic Chief Medical Officer
Sold at will
$50.60K 6,097 at 8.30
6.4%
Not planned
2 Mar 2026
Jendusa Nicholas Adam Principal Accounting Officer
Sold at will
$48.55K 190 at 255.51
38.3%
Not planned
2 Mar 2026
Nassy Michael G. Sr EVP, Chief Credit Officer
Sold at will
$48.24K 3,100 at 15.56
5.3%
Not planned
2 Mar 2026
Poulton Stuart EVP, Chief Development Officer
Sold at will
$48.00K 5,101 at 9.41
5.1%
Not planned
2 Mar 2026
Rangwala Reshma EVP & Chief Medical Officer
Sold at will
$47.67K 5,066 at 9.41
8.2%
Not planned
2 Mar 2026
Weinberg Uri Chf Medical and Innovation Ofr
Sold at will
$43.61K 3,272 at 13.33
1.4%
Not planned
2 Mar 2026
Cheng Sohanya Roshan EVP & Chief Commercial Officer
Sold at will
$43.32K 4,604 at 9.41
4.1%
Not planned
2 Mar 2026
Saint Sean President & CEO
Sold at will
$41.83K 3,384 at 12.36
0.8%
Not planned
2 Mar 2026
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold at will
$37.21K 1,632 at 22.80
3.2%
Not planned
2 Mar 2026
Kavanaugh Ashley VP, Principal Accting Officer · indirect
Sold at will
$35.01K 836 at 41.88
48.5%
Not planned
2 Mar 2026
Sold at will
$33.84K 1,802 at 18.78
2.6%
Not planned
2 Mar 2026
Mano Michael EVP, CLO&Secretary
Sold at will
$33.18K 3,526 at 9.41
3.6%
Not planned
2 Mar 2026
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER
Sold at will
$32.00K 5,894 at 5.43
3.2%
Not planned
2 Mar 2026
Dananberg Jamie CHIEF MEDICAL OFFICER
Sold at will
$31.60K 5,820 at 5.43
4.5%
Not planned
2 Mar 2026
Cushman Elizabeth C. EVP, GC AND SECRETARY
Sold at will
$30.40K 263 at 115.58
0.7%
Not planned
2 Mar 2026
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$30.17K 5,566 at 5.42
3.5%
Not planned
2 Mar 2026
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER
Sold at will
$30.16K 5,565 at 5.42
3.2%
Not planned
2 Mar 2026
Amato Gerald Director
Sold at will
$28.30K 2,000 at 14.15
3.1%
Not planned
2 Mar 2026
Vieira Cory Chief Accounting Officer
Sold at will
$27.19K 2,490 at 10.92
14.1%
Not planned
2 Mar 2026
Horton Amy VP, Chief Accounting Officer
Sold at will
$24.37K 641 at 38.02
0.5%
Not planned
2 Mar 2026
Sold at will
$24.10K 500 at 48.20
4.2%
Not planned
2 Mar 2026
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$23.52K 4,339 at 5.42
2.3%
Not planned
2 Mar 2026
Sachdeva Prerna Chief Accounting Officer
Sold at will
$22.85K 1,352 at 16.90
2.1%
Not planned
2 Mar 2026
Hawkins Mark J Director
Sold at will
$22.43K 133 at 168.62
1.3%
Not planned
2 Mar 2026
Feeley Kevin CHIEF FINANCIAL OFFICER
Sold at will
$22.25K 287 at 77.52
2.9%
Not planned
2 Mar 2026
Crum Richard Francis EVP, Chief Prod & Tech Officer
Sold at will
$20.29K 6,262 at 3.24
1.8%
Not planned
2 Mar 2026
Garcia Susan GC & Chief Compliance Officer
Sold at will
$19.30K 5,956 at 3.24
3.7%
Not planned
2 Mar 2026
Gotlib Phyllis President, International
Sold at will
$18.72K 3,573 at 5.24
3.0%
Not planned
2 Mar 2026
Beneski Benjamin Machinas SVP, Chief Technical Officer
Sold at will
$18.54K 7,132 at 2.60
3.4%
Not planned
2 Mar 2026
Feider Stephen Chief Financial Officer
Sold at will
$17.65K 1,428 at 12.36
0.8%
Not planned
2 Mar 2026
Lehman David Aaron GENERAL COUNSEL
Sold at will 4×
$17.50K 12,237 at 1.43
4.8%
Not planned
2 Mar 2026
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$17.14K 8,071 at 2.12
6.8%
Not planned
2 Mar 2026
Lennon David James CHIEF EXECUTIVE OFFICER
Sold at will
$16.88K 5,100 at 3.31
10.3%
Not planned
2 Mar 2026
BASTA JAMES EVP, General Counsel
Sold at will
$16.69K 1,211 at 13.78
0.8%
Not planned
2 Mar 2026
Abi-Saab Walid Chief Medical Officer
Sold at will
$16.52K 1,660 at 9.95
1.1%
Not planned
2 Mar 2026
Aoki Ichiro President
Sold at will 2×
$16.29K 4,573 at 3.56
4.3%
Not planned
Showing 15,401–15,450 of 23,196. ← Newer Page 309 of 464 Older →